Takeda Announces Details of New Business Venture with Teva in Japan
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is largely controlled by institutional shareholders who own 55% of the company - Simply Wall St News
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
DEF 14A
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Teva Pharmaceutical to buy drug maker Auspex - L.A. Business First
Would Shareholders Who Purchased Teva Pharmaceutical Industries' (NYSE:TEVA) Stock Five Years Be Happy With The Share price Today?
Teva Pharmaceuticals - Wikipedia
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
6 Reasons Buffett Bought Into Teva Pharmaceutical, As Told by a Teva Shareholder | Business Markets and Stocks News | madison.com
Teva: Great Investment With An Upside Even In Volatile Markets (NYSE:TEVA) | Seeking Alpha
Definitive Proxy Statement
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is largely controlled by institutional shareholders who own 55% of the company - Simply Wall St News
What Kind Of Shareholders Hold The Majority In Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Shares?
Teva Pharmaceutical Industries Settles $420 Million Shareholder Lawsuit
Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
What Kind Of Shareholders Hold The Majority In Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Shares?
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners | Ctech
DEF 14A
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters